PharmassêtX Inc., a late-preclinical stage pharmaceutical development company, today announced that the US Patent and Trademark Office has acknowledged receipt of the Company's patent application ...

Moleculin Biotech (MBRX) announced new findings supporting the ability of Annamycin to overcome resistance to Venetoclax in acute myeloid leukemia. This includes data from preclinical in vitro studies ...

“Patients treated with the venetoclax-obinutuzumab combination showed a statistically significant sustained prolongation of PFS compared with patients treated with chlorambucil-obinutuzumab (76. ...

Moto Guzzi has unwrapped a new special edition ‘Wind Tunnel’ V100 Mandello model to its sports tourer range, as a nod to the ...

Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting ...

It's anyone's guess what Cadillac's first-ever electric V series car will be, but we know the brand's performance sub-brand will pivot from the high-performance, gas-fed cars it's known for to EVs ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

It's as much a rattling ball of V-twin angst as it is a jovial ... but doing so in a package that is 100 percent new (this engine does not share even one component with previous Mandela engines ...

It's as much a rattling ball of V-twin angst as it is a jovial ... Meeting Euro 5 emissions standards is a process in and of itself, but doing so in a package that is 100 percent new (this engine does ...

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and ...